Strategies to Address Chimeric Antigen Receptor Tonic Signaling

Area of Science:

• Immunology
• Cancer Therapy
• Molecular Biology

Background:

• Adoptive cell transfer with chimeric antigen receptors (CAR) shows promise for B-cell malignancies but struggles in solid tumors.
• Constitutive tonic signaling in CARs, independent of ligand, is a recognized issue causing poor efficacy, survival, and persistence.
• Ligand-dependent tonic signaling can also cause toxicity, T-cell anergy, exhaustion, and activation-induced cell death.

Purpose of the Study:

• To review the mechanisms of CAR tonic signaling.
• To highlight the impact of structural and methodological changes on CAR signaling.
• To present strategies for preventing and managing CAR tonic signaling.

Main Methods:

• Review of existing literature on CAR tonic signaling.
• Analysis of mechanisms underlying constitutive and ligand-dependent tonic signaling.
• Exploration of endogenous T-cell receptor (TCR) tonic signaling for comparative insights.

Main Results:

• Subtle structural or transduction methodology changes can significantly alter CAR tonic signaling effects.
• Unconstrained tonic signaling leads to diminished antitumor efficacy and T-cell persistence.
• Ligand-dependent tonic signaling can be harnessed to enhance CAR T-cell persistence and efficacy.

Conclusions:

• Understanding and controlling CAR tonic signaling is essential for optimizing adoptive cell therapy.
• Strategies to mitigate deleterious tonic signaling are critical for improving patient outcomes.
• Leveraging ligand-dependent tonic signaling presents opportunities for enhancing CAR T-cell therapy effectiveness.